Financial Data and Key Metrics Changes - Consolidated gross profit for Q1 2025 was $22 million, a 7.9% increase over Q1 2024, marking the highest gross profit in the past twelve quarters [21] - Adjusted EBITDA for Q1 2025 was $7.8 million, compared to $6.2 million for Q1 2024, reflecting a growth of 14.4% [21] - Adjusted EPS for Q1 2025 was $0.63, up from $0.53 in Q1 2024, indicating an 18.9% increase [21] Business Line Data and Key Metrics Changes - In healthcare, gross profit for Q1 2025 was $12.2 million, compared to $11.1 million in Q1 2024, growing 10.2% [21] - Engineering gross profit for Q1 2025 was $6.2 million, up from $5.5 million in Q1 2024, a growth of 12.4% [22] - In IT, life sciences, and data solutions, gross profit for Q1 2025 was $3.6 million, down from $3.8 million in Q1 2024, a decline of 5.3% [25] Market Data and Key Metrics Changes - School revenue for Q1 2025 was $37.3 million, compared to $31.9 million in Q1 2024, reflecting a growth of 16.7% [22] - Non-school revenue for Q1 2025 was $6 million, slightly down from $6.3 million in Q1 2024, but would have been $5.5 million versus $5.1 million if excluding a large long-term care group [22] Company Strategy and Development Direction - The company is focused on cultivating the next generation of leadership and enhancing operational efficiency to ensure long-term success [4] - There is a strong emphasis on revenue expansion and new client acquisition, particularly in the healthcare and engineering sectors [6][9] - The company is capitalizing on technological advancements in AI and machine learning, with a significant expansion in manufacturing across its life sciences client base [7][8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating macroeconomic uncertainties, focusing on secular themes that can drive growth [30] - The outlook for the business is strong, with expectations of continued low double-digit growth in adjusted EBITDA throughout fiscal 2025 [26] - Management anticipates Q4 2025 will produce the highest adjusted EBITDA quarter for the year [26] Other Important Information - The company has retired over 300,000 shares year-to-date, bringing the total repurchase over the last five years to nearly half of shares outstanding [20] - The balance sheet remains clean with significant financial flexibility and resilient organic growth [20] Q&A Session Summary Question: Is political policy uncertainty affecting the business? - Management indicated that they have not encountered significant issues related to the macroeconomic environment and are focused on leveraging secular themes for growth [30] Question: Regarding healthcare gross margins, is the lower margin due to legacy business? - Management clarified that the lower gross margin is more of a quarterly fluctuation rather than a trend, with expectations for improvement in Q2 [32][33]